EPISODE · Feb 29, 2008 · 6 MIN
ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
from Audio Medica News - Medical News Interviews · host Martin Dreyling, University Hospital Grosshaden, Munich
Audio Journal of Oncology, February 26th, 2008 Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma MARTIN DREYLING, University Hospital Grosshaden, Munich REFERENCE: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He gave Peter Goodwin his latest data on combination therapy using the antibody, rituximab, and the emerging rôles of other targeted agents.
NOW PLAYING
ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m